Carnitine Levels and Carnitine Supplementation in Type I Diabetes
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether type I diabetics with carnitine deficiency
exhibit increased numbers of hypoglycemic (low blood sugars) events and if unrecognized
hypoglycemia occurs during continuous 72-hour glucose monitoring. If they are determined to
have unrecognized hypoglycemia, then oral carnitine supplementation will be given to those
subjects and they will be reassessed for the number of hypoglycemic events in a 72-hour
glucose monitoring.
Details
Lead Sponsor:
Children's Mercy Hospital Kansas City
Collaborators:
Leadiant Biosciences, Inc. Minimed Pharmaceuticals Pharmacia/Upjohn Career Development Award Sigma Tau Pharmaceuticals, Inc.